These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 16639795)

  • 21. Bisphosphonates, osteonecrosis of the jaw, and dental treatment recommendations.
    Radfar L; Masood F
    J Okla Dent Assoc; 2008; 99(7):28-9. PubMed ID: 18595621
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Beyond bisphosphonates: thrombophilia, hypofibrinolysis, and jaw osteonecrosis.
    McMahon RE; Bouquot JE; Glueck CJ; Griep J
    J Oral Maxillofac Surg; 2006 Nov; 64(11):1704-5. PubMed ID: 17052602
    [No Abstract]   [Full Text] [Related]  

  • 23. [Bisphosphonates-associated osteonecrosis of the jaw: review on reported cases].
    Gering A; Grange L; Villier C; Woeller A; Mallaret M
    Therapie; 2007; 62(1):49-54. PubMed ID: 17374348
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Bisphosphonates and osteonecrosis of the jaws.
    Mariotti A
    J Dent Educ; 2008 Aug; 72(8):919-29. PubMed ID: 18676801
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Intravenous bisphosphonates and osteonecrosis.
    Greenberg MS
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2004 Sep; 98(3):259-60. PubMed ID: 15356460
    [No Abstract]   [Full Text] [Related]  

  • 26. The bisphosphonates struggle.
    Johnston JW
    J Mich Dent Assoc; 2006 Oct; 88(10):12. PubMed ID: 17078336
    [No Abstract]   [Full Text] [Related]  

  • 27. Expert panel recommendations for the prevention, diagnosis, and treatment of osteonecrosis of the jaws.
    LDA J; 2005; 64(3):21-4. PubMed ID: 16639794
    [No Abstract]   [Full Text] [Related]  

  • 28. [Bisphosphonates and osteonecrosis of the jaw].
    Saussez S; Filleul O; Loeb I
    Rev Stomatol Chir Maxillofac; 2008 Dec; 109(6):367-73. PubMed ID: 19013624
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [Avascular jaw osteonecrosis associated with bisphophonate therapy].
    Broglia C; Merlati G; Valentino F; Benatti C; Gobbi P; Ascari E
    Recenti Prog Med; 2006 Mar; 97(3):140-4. PubMed ID: 16700419
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Bisphosphonates and their impact on patient treatment.
    Kurtzman GM; Silverstein LH; Peden J
    Pract Proced Aesthet Dent; 2006 Jun; 18(5):297-8. PubMed ID: 16903540
    [No Abstract]   [Full Text] [Related]  

  • 31. Bisphosphonates and oral health.
    Ritter AV; Padilla R
    J Esthet Restor Dent; 2008; 20(1):74-5. PubMed ID: 18237344
    [No Abstract]   [Full Text] [Related]  

  • 32. Oral bisphosphonate therapy and osteonecrosis of the jaw: what to tell the concerned patient.
    Koka S; Clarke BL; Amin S; Gertz M; Ruggiero SL
    Int J Prosthodont; 2007; 20(2):115-22. PubMed ID: 17455429
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Reduced serum levels of Interleukin 17 in patients with osteonecrosis of the jaw and in multiple myeloma subjects after bisphosphonates administration.
    Oteri G; Allegra A; Bellomo G; Alonci A; Nastro E; Penna G; Catalfamo L; Cicciù D; De Ponte FS; Musolino C
    Cytokine; 2008 Aug; 43(2):103-4. PubMed ID: 18585926
    [No Abstract]   [Full Text] [Related]  

  • 34. Why osteonecrosis of the jaw after bisphosphonates treatment is more frequent in multiple myeloma than in solid tumors.
    Delibasi T; Altundag K; Kanlioglu Y
    J Oral Maxillofac Surg; 2006 Jun; 64(6):995-6. PubMed ID: 16713825
    [No Abstract]   [Full Text] [Related]  

  • 35. Bisphosphonates and jaw osteonecrosis: the UAMS experience.
    Clarke BM; Boyette J; Vural E; Suen JY; Anaissie EJ; Stack BC
    Otolaryngol Head Neck Surg; 2007 Mar; 136(3):396-400. PubMed ID: 17321866
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Tooth extraction: Is it inciting event or sequela of osteonecrosis of the jaws associated with intravenous bisphosphonates?
    Altundag K; Bulut N; Tezcan E; Ozen M; Purnak T
    J Oral Maxillofac Surg; 2007 Jan; 65(1):154. PubMed ID: 17174785
    [No Abstract]   [Full Text] [Related]  

  • 37. Bisphosphonates and osteonecrosis of the jaws: science and rationale.
    Gutta R; Louis PJ
    Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2007 Aug; 104(2):186-93. PubMed ID: 17448709
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Osteonecrosis of the jaw due to bisphosphonates.
    Prescrire Int; 2008 Oct; 17(97):202-3. PubMed ID: 19536938
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Bisphosphonate-associated osteonecrosis of the jaws: the limits of a conservative approach.
    Tirelli G; Biasotto M; Chiandussi S; Dore F; De Nardi E; Di Lenarda R
    Head Neck; 2009 Sep; 31(9):1249-54. PubMed ID: 19260132
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Bisphosphonate-related osteonecrosis of jaw in the adjuvant breast cancer setting: risks and perspective.
    Shapiro CL
    J Clin Oncol; 2013 Jul; 31(21):2648-50. PubMed ID: 23796994
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.